Precision BioSciences Inc Stock
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Precision BioSciences Inc.
Based on the current price of 0.35 € the target price of 2 € shows a potential of 474.71% for Precision BioSciences Inc which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Precision BioSciences Inc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Precision BioSciences Inc in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Precision BioSciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Precision BioSciences Inc | - | - | - | - | - | - | - |
| Stoke Therapeutics Inc | -8.850% | -3.636% | - | - | - | - | - |
| Personalis Inc | -5.570% | 0.869% | -12.377% | -45.442% | -44.183% | -93.941% | - |
| Immuron | 2.780% | -0.917% | -9.244% | 23.429% | 29.341% | -49.296% | - |
Comments
Precision BioSciences, Inc. (NASDAQ: DTIL) had its price target raised by analysts at HC Wainwright to $60.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DTIL provided by MarketBeat
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Show more
Ratings data for DTIL provided by MarketBeat
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Show more
Ratings data for DTIL provided by MarketBeat